Molly Fellin Spence of Clarivate discusses the FDA’s efforts towards advancing the development of products for CNS metastases, where effective treatments and clinica...

Drug discovery and development, while usually a role of the pharmaceutical industry, is a long, difficult and expensive process, which can present academic organisat...

Adam Istas, DIA explores how global regulators are responding to dramatic increases in cell and gene-based products in development. Regulators are working to provide...

LOINC is an internationally recognized classification system and is often requested in regulatory data submissions to provide context to clinical measurement data su...

The FDA has been promoting innovative and disruptive approaches towards modernizing drug development and clinical trials, which the industry has been slow to adopt. ...

Dr Balamuralidhara V. et al of the JSS College of Pharmacy present a study which examines the clinical evaluation and post-marketing surveillance requirements of med...

Orphan drug discovery presents both opportunities and challenges, with research in this space having some of the highest hurdles in medicine. Clinical trial design a...

Eye health and vision has a major impact on the quality of life, and as such the development of products within this area is a lucrative market. Therapeutic research...

Adult onset Still’s disease (AOSD) is a rare inflammatory joint disease of unknown aetiology, characterised by arthritis, fevers spiking once or twice a day, salmon-...